Cargando…

Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway

Aberrant glycosylation is recognized as a cancer hallmark that is associated with cancer development and progression. In this study, the clinical relevance and significance of terminal fucose (TFG), by fucosyltransferase-1 (FUT1) in carcinogenesis and progression of cholangiocarcinoma (CCA) were dem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Indramanee, Somsiri, Sawanyawisuth, Kanlayanee, Silsirivanit, Atit, Dana, Paweena, Phoomak, Chatchai, Kariya, Ryusho, Klinhom-on, Nathakan, Sorin, Supannika, Wongkham, Chaisiri, Okada, Seiji, Wongkham, Sopit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872661/ https://www.ncbi.nlm.nih.gov/pubmed/31754244 http://dx.doi.org/10.1038/s41598-019-53601-8

Ejemplares similares

Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB
por: Phoomak, Chatchai, et al.
Publicado: (2016)

High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation
por: Phoomak, Chatchai, et al.
Publicado: (2017)

O‐GlcNAc‐induced nuclear translocation of hnRNP‐K is associated with progression and metastasis of cholangiocarcinoma
por: Phoomak, Chatchai, et al.
Publicado: (2019)

O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1
por: Phoomak, Chatchai, et al.
Publicado: (2018)

Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma
por: Sungwan, Prin, et al.
Publicado: (2021)

Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process
por: Dana, Paweena, et al.
Publicado: (2017)

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
por: Klinhom-on, Nathakan, et al.
Publicado: (2021)

Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
por: Saisomboon, Saowaluk, et al.
Publicado: (2019)

Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1-related anti-apoptotic proteins
por: Saranaruk, Paksiree, et al.
Publicado: (2020)

Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients
por: Wattanavises, Sasiprapa, et al.
Publicado: (2019)

Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway
por: Dana, Paweena, et al.
Publicado: (2021)

A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin
por: Teeravirote, Karuntarat, et al.
Publicado: (2021)

Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2019)

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma
por: Obchoei, Sumalee, et al.
Publicado: (2011)

γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus
por: Saengboonmee, Charupong, et al.
Publicado: (2023)

Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients
por: Saranaruk, Paksiree, et al.
Publicado: (2023)

Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma
por: Sribenja, Sirinapa, et al.
Publicado: (2013)

Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells
por: Saentaweesuk, Waraporn, et al.
Publicado: (2018)

Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis()()
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2018)

Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma
por: Tummanatsakun, Doungdean, et al.
Publicado: (2019)

Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma
por: Kotepui, Kwuntida U, et al.
Publicado: (2022)

Establishment and characterization of a novel cancer stem‐like cell of cholangiocarcinoma
por: Panawan, Orasa, et al.
Publicado: (2023)

Reversine, a selective MPS1 inhibitor, induced autophagic cell death via diminished glucose uptake and ATP production in cholangiocarcinoma cells
por: Prajumwongs, Piya, et al.
Publicado: (2021)

A Novel Predictive Equation for Potential Diagnosis of Cholangiocarcinoma
por: Kraiklang, Ratthaphol, et al.
Publicado: (2014)

Aberrant Expression of NF-κB in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy
por: Seubwai, Wunchana, et al.
Publicado: (2014)

High Monopolar Spindle 1 Is Associated with Short Survival of Cholangiocarcinoma Patients and Enhances the Progression Via AKT and STAT3 Signaling Pathways
por: Prajumwongs, Piya, et al.
Publicado: (2021)

High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8
por: Thonsri, Unchalee, et al.
Publicado: (2020)

Establishment of an Allo-Transplantable Hamster Cholangiocarcinoma Cell Line and Its Application for In Vivo Screening of Anti-Cancer Drugs
por: Puthdee, Nattapong, et al.
Publicado: (2013)

Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients
por: Chua-on, Daraporn, et al.
Publicado: (2020)

Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells
por: Seubwai, Wunchana, et al.
Publicado: (2016)

High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation
por: Saengboonmee, Charupong, et al.
Publicado: (2016)

Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma
por: Yosudjai, Juthamas, et al.
Publicado: (2019)

Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor
por: Obchoei, Sumalee, et al.
Publicado: (2022)

Monosodium Glutamate (MSG) Renders Alkalinizing Properties and Its Urinary Metabolic Markers of MSG Consumption in Rats
por: Nahok, Kanokwan, et al.
Publicado: (2019)

Membrane glycomics reveal heterogeneity and quantitative distribution of cell surface sialylation
por: Park, Diane Dayoung, et al.
Publicado: (2018)

Proteomic Studies of Cholangiocarcinoma and Hepatocellular Carcinoma Cell Secretomes
por: Srisomsap, Chantragan, et al.
Publicado: (2010)

Inhibitory Effect of Aspirin on Cholangiocarcinoma Cells
por: Boueroy, Parichart, et al.
Publicado: (2017)

A Recombinant Matrix Metalloproteinase Protein from Gnathostoma spinigerum for Serodiagnosis of Neurognathostomiasis
por: Janwan, Penchom, et al.
Publicado: (2013)

Lactic acidosis induces metabolic and phenotypic reprogramming in cholangiocarcinoma cells via the upregulation of thrombospondin‐1
por: Thamrongwaranggoon, Ubonrat, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma
por: Sawanyawisuth, Kanlayanee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ea1t8qu1o64g513a2q4bp7mka5